Ropes & Gray represented Sanofi Ventures in its investment in Curevo Vaccine’s $110 million Series B financing. Curevo is a privately-held clinical-stage biotechnology company dedicated to developing varicella zoster virus (VZV) vaccines
The Ropes & Gray team included venture capital and emerging companies counsel Michael Connolly, venture capital and emerging companies associate Derek Mubiru, and venture capital and emerging companies partner Rajarshi Banerjee.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.